Swiss chemicals giant Clariant and its US rival Hunstman have axed their US$20 billion merger after it came under attack from an activist investor group.
The two companies said Friday, October 27, that they decided call the deal off because of doubts that Clariant would be able to get the backing of enough shareholders to push the deal through.
The deal was undermined by White Tale Holdings, an activist investor who vocally opposed the merger and bought up Clariant shares in an effort to derail it.
White Tale, a partnership between hedge funds Corvex and 40 North, now claims to be the Swiss chemical giant’s biggest shareholder. “The proposed transaction has no strategic merit,” White Tale wrote in a letter published last month. “It both significantly destroys existing Clariant shareholder value and prevents Clariant from pursuing multiple alternative and immediate opportunities to unlock value for its shareholders.”
The successful revolt comes amid a wave of investor activism in Switzerland, where Credit Suisse and Nestle both face demands for change.
Clariant’s Chief Executive Hariolf Kottmann said the company still had options to explore after further talks with White Tale, which had so far not presented the company with an alternative plan.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Pork Industry Faces Legal Challenges as Antitrust Lawsuits Against Seaboard Foods Dismissed
Oct 2, 2024 by
CPI
CMA Strengthens Investigation with Advisory Panel of Veterinary Experts
Oct 2, 2024 by
CPI
US Merchants Sue Visa, Alleging Unfair Dominance in Debit Card Market
Oct 2, 2024 by
CPI
European Commission Appoints New Chief Competition Economist
Oct 2, 2024 by
CPI
EU Commission Requests Information from YouTube, Snapchat, TikTok on Algorithm Usage
Oct 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh